Chargement des cours...
Prévisions
Aucune donnée d'analyste n'est disponible pour cette entreprise.
Actualités Accéder au fil d'actualités
Nakamoto keeps chief medical officer after reverse merger with KindlyMD
Nakamoto retained a Chief Medical Officer because it merged with healthcare provider KindlyMD and must maintain an operating healthcare arm to meet Nasdaq listing rules and avoid shell-company status. The legacy medical business supplies most of Nakamoto’s modest recurring revenue while the crypto treasury side faces scrutiny after a reported $238 million net loss, roughly $200 million in debt and heavy shareholder dilution from recent acquisitions. Management implemented a 1-for-40 reverse split to regain Nasdaq compliance; upcoming insider lock-up releases and the Q2 filing in August will test whether new revenues justify recent deals. » Plus sur finance.yahoo.com
KindlyMD renames itself Nakamoto and pivots business toward Bitcoin
KindlyMD has officially changed its name to Nakamoto Inc. and is positioning itself going forward as a Bitcoin-focused company, while the healthcare business will continue under the subsidiary Kindly LLC. Shares and warrants will continue to trade on NASDAQ under the tickers NAKA and NAKAW. Nakamoto says it has built a Bitcoin reserve of more than $500 million and has invested in strategic international investments; the company plans to continue disciplined accumulation of its holdings and to build a portfolio of Bitcoin-native companies. » Plus sur de.investing.com
KindlyMD announces share buyback program after massive price slump
KindlyMD approved a share buyback program for its outstanding common shares after the stock lost nearly 98% in six months and is trading close to its 52-week low. Management may make purchases in the market, in privately negotiated transactions and in block trades under Rule 10b-18; the program does not commit to acquiring a fixed number of shares. Despite the buyback plan, the company has high indebtedness and a very low short-term liquidity ratio of 0.13; at the same time KindlyMD secured a loan of USD 203 million to repay a convertible note and appointed new finance chiefs, while B. Riley issued a buy recommendation with a USD 2.00 price target. » Plus sur de.investing.com
Données financières de l'entreprise
| (EUR) | juin 2026 | |
|---|---|---|
| Chiffre d'affaires | 31,43 Mio | 8.967,67% |
| Bénéfice brut | 18,17 Mio | 5.241,81% |
| Bénéfice net | −116,53 Mio | 5.590,36% |
| EBITDA | −99,15 Mio | 4.855,53% |
Données fondamentales
| Indicateur | Valeur |
|---|---|
Capitalisation boursière | 58,42 Mio€ |
Nombre d'actions | 6,02 Mio |
Plus haut/bas sur 52 semaines | 29,85€ - 0,56€ |
| Dividendes | Non |
Bêta | -0,9 |
Ratio P/E | −0,21 |
Ratio PEG | 0,01 |
Ratio P/B | 0,65 |
Ratio P/S | 3,39 |
Profil de l'entreprise
| Nom | KINDLY MD INC. DL-,001 |
| PDG | Timothy Pickett |
| Employés | 23 |
Symboles boursiers
| Bourse | Symbole |
|---|---|
NASDAQ | KDLY |
Découvrir des actifs
Les actionnaires de KINDLY MD INC. DL-,001 investissent également dans les actifs suivants

